Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate

Abstract

Renal survival is good if patients with iMN and renal insufficiency are treated with oral cyclophosphamide. However, side effects occur frequently and relapse rate is high during longer follow-up.